Sharada Shenvi Labadie

USPTO Granted Patents = 25 (Patent Applications = 10)

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 6.7

ph-index = 8

Forward Citations = 144(Granted Patents)

Location History:

South San Francisco, CA (US) (2018)
Sunnyvale, CA (US) (1994 - 2021)

Company Filing History:

Hoffmann-La Roche Inc.

patents

6. 2 out of 54

Constellation Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358951 - Cyclic peptide antibiotics (2025-07-15),

2. 12233052 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2025-02-25),

3. 10966963 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2021-04-06),

4. 10654867 - Heteroaryl estrogen receptor modulators and uses thereof (2020-05-19),

5. 10053451 - Heterocyclic estrogen receptor modulators and uses thereof (2018-08-21),

6. 10035801 - Pyrazolo compounds and uses thereof (2018-07-31),

7. 10023589 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2018-07-17),

8. 10022354 - Pyrrolidine amide compounds as histone demethylase inhibitors (2018-07-17),

9. 9980947 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2018-05-29),

10. 9969732 - Tetrahydroisoquinoline estrogen receptor modulators and uses thereof (2018-05-15),

11. 9255110 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators (2016-02-09),

12. 8461328 - Tricyclic heterocyclic compounds, compositions and methods of use thereof (2013-06-11),

13. 8071797 - Heterocyclic antiviral compounds (2011-12-06),

14. 7186841 - Antiinflammation agents (2007-03-06),

15. 7176314 - Inflammation modulators (2007-02-13),

Hello! I'd be happy to assist you with the article about inventor Sharada Shenvi Labadie. Here's the structured content based on the data provided:

Title: Innovator Spotlight - Sharada Shenvi Labadie

Introduction:

Sharada Shenvi Labadie is a prolific inventor based in Sunnyvale, CA, with an impressive portfolio of 23 patents. His innovative work in the field of pharmaceuticals has made a significant impact on the industry.

Latest Patents:

1. Tetrahydro-pyrido[3,4-b]indole Estrogen Receptor Modulators: Labadie's recent patent involves compounds with estrogen receptor modulation activity, paving the way for new treatments for estrogen receptor-dependent conditions. The patent includes detailed structures and pharmaceutical applications.

2. Heteroaryl Estrogen Receptor Modulators: Another patent showcases Labadie's expertise in designing heteroaryl compounds with estrogen receptor modulation properties, expanding the range of potential therapeutics for estrogen receptor-related diseases.

Career Highlights:

Labadie has made notable contributions to leading companies such as Genentech, Inc., and Syntex (USA) Inc. His groundbreaking research and patent portfolio have solidified his position as a key player in the pharmaceutical innovation space.

Collaborations:

Throughout his career, Labadie has collaborated with accomplished professionals in the industry, including Francisco Xavier Talamas and Eric Brian Sjogren. These collaborations have not only enriched his work but also led to the development of novel pharmaceutical solutions.

Conclusion:

Inventor Sharada Shenvi Labadie's relentless pursuit of innovation and scientific excellence has resulted in a remarkable patent portfolio that continues to push the boundaries of pharmaceutical research. His contributions to the field underscore his commitment to advancing healthcare through groundbreaking inventions.

If you need further information or assistance, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.